Skip to content

The Different Response of Endocrine Hormones to Hypoglycemia in Patients With Type 1 or Type 2 Diabetes

A Study of Endocrine Hormone Changes in Newly Diagnosed Patients With Type 2 and Type 1 Diabetes Using Hyperinsulinaemic Hypoglycaemic Clamp Technique

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05290207
Enrollment
35
Registered
2022-03-22
Start date
2022-01-06
Completion date
2022-09-16
Last updated
2023-05-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Endocrine hormones, not only blood glucose responsive hormones, but also sexual hormones, thyroid hormones, growth hormones and so on, may have response and activites in hypoglycemia. However, the different responses of endocrine hormones to hypoglycemia in patients With diabetes remain unclear.

Detailed description

This study will observe the changes of insulin, C-peptide, glucagon, growth hormone, IGF-1, ACTH, cortisol, thyroid function, sexual hormone in newly diagnosed men with type 2 and type 1 diabetes mellitus using hyperinsulinaemic hypoglycaemic clamp technique

Interventions

DIAGNOSTIC_TESTThe hyperinsulinaemic hypoglycaemic clamp

Glucose will be clamped at 5.0 mmol/L for approximately 30 minutes, and then be lowered to 3.0 mmol/L for 30 minutes

Sponsors

Nanjing First Hospital, Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
18 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

\- Patients * newly diagnosed male patients with type 1 or type 2 diabetes (diagnostic criteria of World Health Organization) * aged 18-50 years * has not been treated with any hypoglycemic drugs * HbA1c\>9% Normal subjects: healthy and had no known illness

Exclusion criteria

* patients with insulin allergy. * any history of hypoglycemic agent intake or were presently taking hypoglycemic agents * any abnormality in liver or kidney function on blood and urine investigations * any history of systemic corticosteroid use in 3 months * any recent infections or acute medical events * any other obvious conditions or associated diseases determined by the researcher: such as severe cardiopulmonary diseases, endocrine diseases, neurological diseases, tumors and other diseases, other pancreatic diseases, history of mental diseases.

Design outcomes

Primary

MeasureTime frameDescription
endocrine hormone changes20 minuteschanges of endocrine hormones during hyperinsulinaemic hypoglycaemic clamps

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026